Ad is loading...
MKKGY
Price
$30.13
Change
-$0.64 (-2.08%)
Updated
Nov 15 closing price
109 days until earnings call
ZTS
Price
$175.14
Change
+$0.51 (+0.29%)
Updated
Nov 15 closing price
93 days until earnings call
Ad is loading...

MKKGY vs ZTS

Header iconMKKGY vs ZTS Comparison
Open Charts MKKGY vs ZTSBanner chart's image
Merck KGaA
Price$30.13
Change-$0.64 (-2.08%)
Volume$167.41K
CapitalizationN/A
ZOETIS
Price$175.14
Change+$0.51 (+0.29%)
Volume$3.43M
CapitalizationN/A
MKKGY vs ZTS Comparison Chart
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MKKGY vs. ZTS commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a StrongSell and ZTS is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MKKGY: $30.13 vs. ZTS: $175.14)
Brand notoriety: MKKGY: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MKKGY: 281% vs. ZTS: 163%
Market capitalization -- MKKGY: $76.59B vs. ZTS: $77.48B
MKKGY [@Pharmaceuticals: Other] is valued at $76.59B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • MKKGY’s TA Score: 4 bullish, 4 bearish.
  • ZTS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MKKGY is a better buy in the short-term than ZTS.

Price Growth

MKKGY (@Pharmaceuticals: Other) experienced а -7.38% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -0.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

MKKGY is expected to report earnings on Mar 06, 2025.

ZTS is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) and MKKGY($76.6B) have the same market capitalization . ZTS has higher P/E ratio than MKKGY: ZTS (32.94) vs MKKGY (21.41). MKKGY YTD gains are higher at: -4.240 vs. ZTS (-10.384). MKKGY has higher annual earnings (EBITDA): 6.45B vs. ZTS (3.67B). ZTS has more cash in the bank: 2.04B vs. MKKGY (1.72B). ZTS has less debt than MKKGY: ZTS (6.76B) vs MKKGY (10.6B). MKKGY has higher revenues than ZTS: MKKGY (22.3B) vs ZTS (8.54B).
MKKGYZTSMKKGY / ZTS
Capitalization76.6B77.5B99%
EBITDA6.45B3.67B176%
Gain YTD-4.240-10.38441%
P/E Ratio21.4132.9465%
Revenue22.3B8.54B261%
Total Cash1.72B2.04B84%
Total Debt10.6B6.76B157%
FUNDAMENTALS RATINGS
MKKGY vs ZTS: Fundamental Ratings
MKKGY
ZTS
OUTLOOK RATING
1..100
5074
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
6355
SMR RATING
1..100
7021
PRICE GROWTH RATING
1..100
7959
P/E GROWTH RATING
1..100
7174
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (27) in the null industry is somewhat better than the same rating for ZTS (76) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew somewhat faster than ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (55) in the Pharmaceuticals Generic industry is in the same range as MKKGY (63) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

ZTS's SMR Rating (21) in the Pharmaceuticals Generic industry is somewhat better than the same rating for MKKGY (70) in the null industry. This means that ZTS’s stock grew somewhat faster than MKKGY’s over the last 12 months.

ZTS's Price Growth Rating (59) in the Pharmaceuticals Generic industry is in the same range as MKKGY (79) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (71) in the null industry is in the same range as ZTS (74) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYZTS
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
57%
Momentum
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
62%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 13 days ago
65%
Bullish Trend 10 days ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 6 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
65%
Aroon
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Ad is loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCSRX8.36N/A
N/A
Fidelity Advisor Strategic Real Ret C
SVXLX56.84-0.26
-0.46%
Smead International Value Inv
TFOIX37.23-0.25
-0.67%
Transamerica Capital Growth I
ASVIX11.46-0.09
-0.78%
American Century Small Cap Value Inv
RYRCX40.90-0.43
-1.04%
Rydex Retailing C

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
-2.08%
MKGAF - MKKGY
49%
Loosely correlated
-1.32%
AMPH - MKKGY
25%
Poorly correlated
-1.00%
ZTS - MKKGY
25%
Poorly correlated
+0.29%
SUPN - MKKGY
25%
Poorly correlated
-1.69%
INDV - MKKGY
24%
Poorly correlated
-3.25%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with SNDL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.29%
SNDL - ZTS
33%
Loosely correlated
N/A
ACET - ZTS
31%
Poorly correlated
-9.82%
EVO - ZTS
27%
Poorly correlated
+6.67%
HLN - ZTS
27%
Poorly correlated
+0.86%
ORGO - ZTS
27%
Poorly correlated
-3.62%
More